{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:39:08Z","timestamp":1781231948861,"version":"3.54.1"},"reference-count":125,"publisher":"Impact Journals, LLC","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,29]]},"DOI":"10.18632\/oncotarget.20409","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T17:05:17Z","timestamp":1503594317000},"page":"78193-78207","source":"Crossref","is-referenced-by-count":17,"title":["Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Kimberly A.","family":"Birnie","sequence":"first","affiliation":[{"name":"Institute for Respiratory Health, Centre for Respiratory Health, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Pr\u00eale","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, Centre for Respiratory Health, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Cell Therapy and Regenerative Medicine, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, Centre for Respiratory Health, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Badrian","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, Centre for Respiratory Health, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Mutsaers","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, Centre for Respiratory Health, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Cell Therapy and Regenerative Medicine, Harry Perkins Institute of Medical Research, QEII Medical Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1357-2725(03)00242-5","article-title":"The mesothelial cell","volume":"36","author":"Mutsaers","year":"2004","journal-title":"The International Journal of Biochemisty & Cell Biology"},{"key":"2","first-page":"113","article-title":"Mesothelial cells in tissue repair and fibrosis","volume":"6","author":"Prele","year":"2015","journal-title":"Front Pharmacol"},{"key":"3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1440-1843.2002.00404.x","article-title":"Mesothelial cells: their structure, function and role in serosal repair","volume":"7","author":"Mutsaers","year":"2002","journal-title":"Respirology"},{"key":"4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.7071597","article-title":"Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey","volume":"216","author":"Fischbein","year":"1982","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2131\/jts.33.105","article-title":"Induction of mesothelioma in p53+\/- mouse by intraperitoneal application of multi-wall carbon nanotube","volume":"33","author":"Kanno","year":"2008","journal-title":"J Toxicol Sci"},{"key":"7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1349-7006.2012.02318.x","article-title":"Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice","volume":"103","author":"Kanno","year":"2012","journal-title":"Cancer Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"e1005633","DOI":"10.1371\/journal.pgen.1005633","article-title":"Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s","volume":"11","author":"Baumann","year":"2015","journal-title":"PLoS Genet"},{"key":"9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10552-009-9357-4","article-title":"Ionizing radiation: a risk factor for mesothelioma","volume":"20","author":"Valberg","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/08958370600835377","article-title":"The role of SV40 in malignant mesothelioma and other human malignancies","volume":"18","author":"Girtsman","year":"2006","journal-title":"Inhal Toxicol"},{"key":"11","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5694\/mja15.01072","article-title":"Asbestos exposure: challenges for Australian clinicians","volume":"204","author":"Nowak","year":"2016","journal-title":"Med J Aust"},{"key":"14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1445-5994.2010.02223.x","article-title":"Malignant mesothelioma","volume":"40","author":"Van Zandwijk","year":"2010","journal-title":"Internal Medicine Journal"},{"key":"15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"Stella","year":"2015","journal-title":"Eur Respir Rev"},{"key":"16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-014-2029-1","article-title":"Advances in malignant peritoneal mesothelioma","volume":"30","author":"Yu","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/thx.37.11.810","article-title":"Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour","volume":"37","author":"Heard","year":"1982","journal-title":"Thorax"},{"key":"18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.109.1.109","article-title":"Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas","volume":"109","author":"Linden","year":"1996","journal-title":"Chest"},{"key":"19","first-page":"283601","article-title":"Primary pericardial mesothelioma: a rare entity","volume":"2013","author":"Yuan","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Berry","year":"2015","journal-title":"J Surg Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/oemed-2015-103309","article-title":"Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009","volume":"73","author":"van Zandwijk","year":"2016","journal-title":"Occup Environ Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10552-016-0825-3","article-title":"Geographic distribution of incidence of pericardial and paratesticular mesotheliomas in the USA","volume":"27","author":"Weiss","year":"2016","journal-title":"Cancer Causes Control"},{"key":"23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12199-007-0017-6","article-title":"Pathology of Mesothelioma","volume":"13","author":"Inai","year":"2008","journal-title":"Environmental Health and Preventive Medicine"},{"key":"24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1183\/09031936.98.12040972","article-title":"Malignant pleural mesothelioma","volume":"12","author":"Astoul","year":"1998","journal-title":"European Respiratory Journal"},{"key":"25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10147-011-0369-1","article-title":"Pathological and molecular biological approaches to early mesothelioma","volume":"17","author":"Nakano","year":"2012","journal-title":"International Journal of Clinical Oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1753465816628800","article-title":"Malignant pleural mesothelioma: an update on diagnosis and treatment options","volume":"10","author":"Nowak","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.11-1303","article-title":"Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients","volume":"142","author":"Lee","year":"2012","journal-title":"Chest"},{"key":"28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","article-title":"CT in differential diagnosis of diffuse pleural disease","volume":"154","author":"Miller","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1445-5994.2011.02451.x","article-title":"Asbestos-related disease","volume":"41","author":"Musk","year":"2011","journal-title":"Internal Medicine Journal"},{"key":"30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","article-title":"Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology","volume":"12","author":"Kobayashi","year":"2015","journal-title":"Cytojournal"},{"key":"31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"Moons","year":"2011","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MCP.0b013e32832b98eb","article-title":"Serum and pleural fluid biomarkers for mesothelioma","volume":"15","author":"Robinson","year":"2009","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.00226111","article-title":"Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma","volume":"41","author":"Syrigos","year":"2013","journal-title":"Eur Respir J"},{"key":"34","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Wali","year":"2005","journal-title":"N Engl J Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2014.02.024","article-title":"Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"433","author":"Hu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Liu","year":"2012","journal-title":"N Engl J Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"84851","DOI":"10.18632\/oncotarget.12707","article-title":"Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"issue":"102","key":"38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0031-1272874","article-title":"Update on Malignant Pleural Mesothelioma","volume":"32","author":"Kindler","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"Alfieri","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"40","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/jco.2003.11.136","article-title":"Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00508-016-1036-3","article-title":"Management of malignant pleural mesothelioma-part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)","volume":"128","author":"Studnicka","year":"2016","journal-title":"Wien Klin Wochenschr"},{"key":"42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2006.06.002","article-title":"The role of radiation therapy in malignant pleural mesothelioma: a systematic review","volume":"80","author":"Evans","year":"2006","journal-title":"Radiother Oncol"},{"key":"43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11864-011-0149-1","article-title":"Novel Targeted Therapies and Vaccination Strategies for Mesothelioma","volume":"12","author":"Nowak","year":"2011","journal-title":"Current Treatment Options in Oncology"},{"key":"44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"van Zandwijk","year":"2016","journal-title":"Epigenomics"},{"key":"45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/030089160509100503","article-title":"Computed tomographic characterization of malignant peritoneal mesothelioma","volume":"91","author":"Sugarbaker","year":"2005","journal-title":"Tumori"},{"key":"46","first-page":"79","article-title":"Diagnosis and management of patients with malignant peritoneal mesothelioma","volume":"7","author":"Burke","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/MCG.0b013e318297fa65","article-title":"Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma","volume":"47","author":"Nakano","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"48","first-page":"472","article-title":"Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical features","volume":"5","author":"Ortac","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00384-014-1875-1","article-title":"Colonic invasion induced by malignant peritoneal mesothelioma","volume":"29","author":"Yu","year":"2014","journal-title":"International Journal of Colorectal Disease"},{"key":"50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11547-015-0609-y","article-title":"CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis","volume":"121","author":"Kang","year":"2016","journal-title":"Radiol Med"},{"key":"51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","article-title":"Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma","volume":"10","author":"Alexander","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00438-010-0556-1","article-title":"Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production","volume":"284","author":"Siomi","year":"2010","journal-title":"Molecular Genetics and Genomics"},{"key":"53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrm1644","article-title":"MicroRNA biogenesis: coordinated cropping and dicing","volume":"6","author":"Kim","year":"2005","journal-title":"Nature Reviews\/Molecular Cell Biology"},{"key":"54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanisms and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/bmc-2014-0012","article-title":"Update on non-canonical microRNAs","volume":"5","author":"Choi","year":"2014","journal-title":"Biomolecular concepts"},{"key":"56","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2006.03.043","article-title":"Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex","volume":"125","author":"Kim","year":"2006","journal-title":"Cell"},{"key":"57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Shiekhattar","year":"2005","journal-title":"Nature"},{"key":"58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the Assembly of the RNAi Enzyme Complex","volume":"115","author":"Zamore","year":"2003","journal-title":"Cell"},{"key":"59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Filipowicz","year":"2010","journal-title":"The Annual Review of Biochemistry"},{"key":"60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tig.2017.01.003","article-title":"Biogenesis and Function of Ago-Associated RNAs","volume":"33","author":"Hansen","year":"2017","journal-title":"Trends in Genetics"},{"key":"61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","article-title":"Genomic Organisation of microRNAs","volume":"222","author":"Patton","year":"2010","journal-title":"Journal of Cell Physiology"},{"key":"63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ebiom.2016.09.017","article-title":"microRNA Therapeutics in Cancer - An Emerging Concept","volume":"12","author":"Calin","year":"2016","journal-title":"EBioMedicine"},{"key":"64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: A new source of biomarkers","volume":"717","author":"Wang","year":"2011","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/path.2806","article-title":"miRNAs in human cancer","volume":"223","author":"Tuschl","year":"2011","journal-title":"Journal of Pathology"},{"key":"66","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014A miRNA microarray analysis","volume":"48","author":"Knuutila","year":"2009","journal-title":"Genes, Chromosomes and Cancer"},{"key":"67","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/0008-5472.can-09-3993","article-title":"hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma","volume":"70","author":"Aharonov","year":"2009","journal-title":"Cancer Research"},{"key":"68","doi-asserted-by":"publisher","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma","volume":"285","author":"Pass","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"69","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncb1258","article-title":"Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance","volume":"7","author":"Blenis","year":"2005","journal-title":"Nat Cell Biol"},{"key":"70","doi-asserted-by":"crossref","first-page":"e4395","DOI":"10.1371\/journal.pone.0004395","article-title":"Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6","volume":"4","author":"Larner","year":"2009","journal-title":"PLoS One"},{"key":"71","first-page":"31","article-title":"The LIN28\/let-7 Pathway in Cancer","volume":"8","author":"Hagan","year":"2017","journal-title":"Front Genet"},{"key":"72","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Nasreen","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"73","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2147\/IJN.S41782","article-title":"Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer","volume":"8","author":"Nasreen","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"74","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.7150\/ijbs.13453","article-title":"Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell","volume":"12","author":"Kim","year":"2016","journal-title":"Int J Biol Sci"},{"key":"75","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Brahmbhatt","year":"2013","journal-title":"Ann Oncol"},{"key":"76","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jtho.2017.05.024","article-title":"Tumour suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma","volume":"12","author":"Boyer","year":"2017","journal-title":"J Thorac Oncol"},{"key":"77","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1158\/1078-0432.ccr-10-3040","article-title":"Epigenetic Silencing of MicroRNA-34b\/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma","volume":"17","author":"Pass","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"78","first-page":"4871","article-title":"MicroRNA miR-34b\/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells","volume":"32","author":"Kishimoto","year":"2012","journal-title":"Anticancer Res"},{"key":"79","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Miyoshi","year":"2013","journal-title":"Oncol Rep"},{"key":"80","first-page":"6223","article-title":"Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma","volume":"35","author":"Santoni-Rugiu","year":"2015","journal-title":"Anticancer Res"},{"key":"81","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Truksa","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"82","doi-asserted-by":"crossref","first-page":"36338","DOI":"10.18632\/oncotarget.8916","article-title":"MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma","volume":"7","author":"Nguyen","year":"2016","journal-title":"Oncotarget"},{"key":"83","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Hoang","year":"2013","journal-title":"Chest"},{"key":"84","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Takeshima","year":"2016","journal-title":"Int J Oncol"},{"key":"85","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijo.2017.3863","article-title":"PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells","volume":"50","author":"Takeshima","year":"2017","journal-title":"Int J Oncol"},{"key":"86","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Panebianco","year":"2014","journal-title":"Oncogene"},{"key":"87","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.stemcr.2017.02.005","article-title":"Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells","volume":"8","author":"Schwaller","year":"2017","journal-title":"Stem Cell Reports"},{"key":"88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-4939-1538-5_23","article-title":"miR-CATCH: microRNA capture affinity technology","volume":"1218","author":"Greene","year":"2015","journal-title":"Methods Mol Biol"},{"key":"89","doi-asserted-by":"crossref","first-page":"e0170999","DOI":"10.1371\/journal.pone.0170999","article-title":"Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing","volume":"12","author":"Greene","year":"2017","journal-title":"PLoS One"},{"key":"90","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/1541-7786.MCR-14-0442","article-title":"Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma","volume":"13","author":"Badrian","year":"2015","journal-title":"Mol Cancer Res"},{"key":"91","first-page":"39","article-title":"Stathmin is overexpressed in malignant mesothelioma","volume":"27","author":"Jablons","year":"2007","journal-title":"Anticancer Res"},{"key":"92","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1091\/mbc.e07-09-0894","article-title":"Stathmin activity influences sarcoma cell shape motility and metastatic potential","volume":"19","author":"Baldassarre","year":"2008","journal-title":"Molecular Biology of the Cell"},{"key":"93","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.18632\/oncotarget.7666","article-title":"microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma","volume":"7","author":"Mairinger","year":"2016","journal-title":"Oncotarget"},{"key":"94","first-page":"3508","article-title":"Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma","volume":"5","author":"Paakko","year":"1999","journal-title":"Clin Cancer Res"},{"key":"95","first-page":"1996","article-title":"MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells","volume":"6","author":"Nasreen","year":"2016","journal-title":"Am J Cancer Res"},{"key":"96","doi-asserted-by":"publisher","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Cooper","year":"2015","journal-title":"Oncotarget"},{"key":"97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-016-0529-z","article-title":"KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma","volume":"15","author":"Lin","year":"2016","journal-title":"Mol Cancer"},{"key":"98","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejcts.2009.08.027","article-title":"Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma","volume":"37","author":"Soltermann","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassan","year":"2012","journal-title":"Mod Pathol"},{"key":"100","first-page":"1700","article-title":"[The MicroRNA miR-205 inhibits epithelial-messenchymal transition in HK-2 cells by down-regulating ZEB1 and ZEB2 expressions]. [Article in Chinese]","volume":"36","author":"Huang","year":"2016","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"101","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"Straw","year":"2007","journal-title":"Cancer Cell"},{"key":"102","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.copbio.2011.04.008","article-title":"Minicells: versatile vectors for targeted drug or si\/shRNA cancer therapy","volume":"22","author":"Brahmbhatt","year":"2011","journal-title":"Curr Opin Biotechnol"},{"key":"103","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregutaled microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Marsit","year":"2010","journal-title":"International Journal of Cancer"},{"key":"104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Goren","year":"2010","journal-title":"Journal of Molecular Diagnostics"},{"key":"105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Santoni-Rugiu","year":"2014","journal-title":"J Mol Diagn"},{"key":"106","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Mutsaers","year":"2012","journal-title":"Journal of Thoracic Oncology"},{"key":"107","doi-asserted-by":"crossref","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","article-title":"Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma \"A Pilot Study\"","volume":"7","author":"Bruning","year":"2012","journal-title":"PLoS ONE"},{"key":"108","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma","volume":"6","author":"Ranaldi","year":"2011","journal-title":"PLoS One"},{"key":"109","first-page":"9280170","article-title":"Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma","volume":"2017","author":"Bruning","year":"2017","journal-title":"Dis Markers"},{"key":"110","doi-asserted-by":"crossref","first-page":"82700","DOI":"10.18632\/oncotarget.12408","article-title":"Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers","volume":"7","author":"Tognon","year":"2016","journal-title":"Oncotarget"},{"key":"111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncy.21646","article-title":"Young investigator challenge: MicroRNA-21\/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Fassina","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"112","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"microRNA signature of malignant meosthlelioma with potential diagnostic and prognostic implications","volume":"42","author":"Gaudino","year":"2010","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"113","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Umemura","year":"2014","journal-title":"Med Oncol"},{"key":"114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Reid","year":"2015","journal-title":"Mol Oncol"},{"key":"115","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"Boldorini","year":"2017","journal-title":"Sci Rep"},{"key":"116","doi-asserted-by":"crossref","first-page":"58606","DOI":"10.18632\/oncotarget.9686","article-title":"Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis","volume":"7","author":"Procopio","year":"2016","journal-title":"Oncotarget"},{"key":"117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-016-0387-6","article-title":"Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism","volume":"10","author":"Zaffaroni","year":"2017","journal-title":"J Hematol Oncol"},{"key":"118","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Hong","year":"2017","journal-title":"Invest New Drugs"},{"key":"119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5582\/bst.2016.01249","article-title":"Progress of research on microRNAs with diagnostic value in asbestos exposure: A call for method standardization","volume":"11","author":"Procopio","year":"2017","journal-title":"Biosci Trends"},{"key":"120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1373\/clinchem.2015.251942","article-title":"Optimization and Standardization of Circulating MicroRNA Detection for Clinical Application: The miR-Test Case","volume":"62","author":"Bianchi","year":"2016","journal-title":"Clin Chem"},{"key":"121","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment","volume":"136","author":"Jaurand","year":"2012","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"122","first-page":"5547","article-title":"Alterations and Deletion Mapping of 9p21-p22 in Malignant Mesothelioma","volume":"54","author":"Testa","year":"1994","journal-title":"Cancer Research"},{"key":"123","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/cas.12752","article-title":"Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model","volume":"106","author":"Tanaka","year":"2015","journal-title":"Cancer Science"},{"key":"124","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s1525-1578(10)60639-3","article-title":"Severe Chromosomal Aberrations in Pleural Mesotheliomas with Unusual Mesodermal Features","volume":"2","author":"Johnen","year":"2000","journal-title":"The Journal of Molecular Diagnostics"},{"key":"125","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","author":"Nonomura","year":"2011","journal-title":"Journal of Clinical Pathology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T01:57:30Z","timestamp":1750816650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":125,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,9,29]]}},"alternative-id":["20409","29100460"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20409","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}